SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

UNCY

Unicycive Therapeutics Inc.
NASDAQHealth Care

Latest close: 3.36 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 29, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 28, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 12, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record27420 flagged findings
Reported transactions (Form 4)47since Jul 11, 2023 · and 1 other holding
Corporate events (8-K)26since Jul 18, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-06-05share offering or dilution eventrecentOpen filing ↗
    “…in any other offering at a price per share that is equal to or greater than the price per share paid by investors in this…”
  • 2026-06-05capital return (buybacks/dividends)recentOpen filing ↗
    “…liability of directors of a corporation to the corporation or its stockholders for monetary damages for a breach of fiduciary…”
    +1 more passage from the same document
    • “…under the indentures with respect to any series of debt securities that we may issue: ● if we fail to pay interest when due and…”
  • 2026-05-12share offering or dilution eventrecentOpen filing ↗
    “…at the option of the holder thereof, each share of Series B-2 Preferred Stock, is convertible into the number of shares of…”
    +1 more passage from the same document
    • “…of Series A-2 Preferred Stock, in lieu of common stock, (ii) a tranche A warrant to acquire approximately 4,667,594 shares…”
  • 2026-05-12capital return (buybacks/dividends)recentOpen filing ↗
    “…requirements associated with such operating plans. If we raise additional funds by issuing equity securities, our stockholders may…”
  • 2026-05-12reverse splitrecentOpen filing ↗
    “…employee’s eligible compensation. Company contributions to the 401(k) Plan totaled approximately $ 42,000 and $ 55,000 for the three…”
    +1 more passage from the same document
    • “…Stockholders’ Equity Authorized Common Stock The Company is authorized to issue up to 400,000,000 shares of common stock at par…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:10 on Jun 20, 2025) · 1:10 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 274)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 1, 26Form 3 ↗Insider transaction
  • Sep 29, 268-K ↗Current report · A senior executive left or was appointed
  • Sep 28, 268-K ↗Current report · Other events
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Vivo Opportunity Fund Holdings, L.P. · 10.0% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Nantahala Capital Management, LLC · 10.0% · event on Jun 30, 26 · amendment
  • Aug 12, 268-K ↗Current report · Results
  • Aug 12, 2610-Q ↗Quarterly report
  • Jul 30, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 5.3% · event on Jun 30, 26
  • Insider transaction · 2 Form 4/A filingsshow all 2hide
  • Jul 8, 26SCHEDULE 13G/A ↗Passive stake · Millennium Management LLC · 1.0% · event on Jun 30, 26 · amendment
  • Jul 2, 268-K ↗Current report · Other events
  • Jul 1, 26Form 144 ↗Notice of proposed sale
  • Jun 22, 26DEFA14A ↗Shareholder meeting and votes
  • Jun 22, 268-K ↗Current report · Shareholder vote results
  • Insider transaction · 6 Form 4/A filingsshow all 6hide
  • Jun 11, 26CORRESP ↗Correspondence with the SEC
  • Jun 11, 26UPLOAD ↗Correspondence with the SEC
  • Jun 5, 268-K ↗Current report · Entered a material agreement
  • Jun 5, 26S-3 ↗Securities offering

274 filings on record, the oldest from Oct 9, 20.

Listing the 25 most recent filings of the 274 on record.

8-Ks, explained

Stress6Structure14Governance6
  • Sep 29, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jun 5, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Apr 6, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 14, 25StructureEntered a material agreement+3 more in the same filing8-K/A 1.01 ↗
  • Jul 15, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jul 15, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Structure3 material agreements entered2024show all 3hide
    • Jul 2, 24StructureEntered a material agreement8-K 1.01 ↗
    • Mar 14, 24StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
    • Mar 14, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Sep 25, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Sep 6, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Aug 31, 23GovernanceAuditor change filing (8-K Item 4.01)8-K 4.01 ↗
  • Jul 31, 23GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • May 23, 23StressListing notice (8-K 3.01)8-K 3.01 ↗

7 older filings not shown

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 6 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Vivo Opportunity Fund Holdings, L.P.10.0%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Nantahala Capital Management, LLC10.0%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • RA Capital Management, L.P.9.9%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Integrated Core Strategies (US) LLC5.5%Jan 16, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • BlackRock, Inc.5.3%Jun 30, 26SCHEDULE 13G ↗
show 3 more holdershide
  • Octagon Capital Advisors LP4.7%Dec 31, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Great Point Partners, LLC4.5%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Millennium Management LLC1.0%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Jul 1, Vivo Opportunity Fund Holdings, L.P. filed notice of intent to sell up to $9.5M. That is about 6.53% of shares outstanding.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

The 90-day window closed with no sale of theirs on record in Form 4.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

No purchases or sales are on record in this stretch; only other transactions (compensation, withholding, exercises or gifts).

Stock compensation, tax and giftsshow the 7 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 25, 25Otheramount n/aGaurav Aggarwal↗
  • Feb 18, 25Otheramount n/aGaurav Aggarwal↗
  • Oct 9, 24Otheramount n/aGaurav Aggarwal↗
  • Jul 11, 23Compensationamount n/aShalabh K. GuptaCEO↗
  • Jul 11, 23Compensationamount n/aPramod GuptaEVP, Pharmaceuticals and BD↗
  • Jul 11, 23Compensationamount n/aDouglas JermasekEVP of Corporate Strategy↗
  • Jul 11, 23Otheramount n/aGaurav Aggarwal↗

The full record holds 7 transactions and goes back to Jul 15, 22.

Its sector and its market

Unicycive Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Unicycive Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Unicycive Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
274 documents on file, from Oct 9, 2020 to Oct 1, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Unicycive Therapeutics Inc. (UNCY): stock price history, insider trades and SEC filings — HornScout